Delivery Order SPE2DR25D9133-SPE2DR26FCFY1
- Not listed
- The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on April 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical product distribution to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge,...
- The Defense Logistics Agency issued a $3,147.70 delivery order to DMS Pharmaceutical Group Inc. on April 15, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of May 6,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 27, 2026, for YF-VAX 1 dose vials with a ceiling value of $3,147.70 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract program authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for YF-VAX 1 dose vials, with a ceiling value of $37,772.40, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS...
- The Defense Logistics Agency issued a $3,777.24 delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for YF-VAX 1 dose vials. Ultimate completion date is April 23, 2026. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a $1,888.62 delivery order to DMS Pharmaceutical Group Inc. on April 16, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, with a ceiling value of $1,259.08, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply across Department of Defense healthcare facilities worldwide. The order is firm fixed price with an ultimate completion date of March 5, 2026. Place...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for YF-VAX 1 dose vials with a ceiling value of $2,518.16 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...
- The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $6,295.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 18, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support military healthcare facilities worldwide. Place of...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFY1Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 17, 2026, for YF-VAX 1 dose vials with a ceiling value of $37,772.40 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order has an ultimate completion date of May 8, 2026. DMS Pharmaceutical is the sole regional prime vendor within PPV-G GEN V and operates on full-and-open terms with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 4/16/26 |